Navigation Links
Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)
Date:5/19/2009

- Results suggest pirfenidone may provide meaningful clinical benefit in IPF patients -

- Results of new analyses of efficacy and safety reported -

- Conference Call and Webcast at 9 p.m. EDT (6 p.m. PDT) -

SAN DIEGO, May 19 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) reported that results from the two Phase 3 CAPACITY studies evaluating pirfenidone in patients with idiopathic pulmonary fibrosis (IPF) were presented today in an oral late-breaker presentation at the International Conference of the American Thoracic Society (ATS) in San Diego. Dr. Paul Noble, co-chair of the CAPACITY program and Professor of Medicine and Chief of Pulmonary, Allergy and Critical Care Medicine at Duke University Medical Center presented details of data from CAPACITY that were previously announced by the company in a press release on February 3, 2009 as well as new information from the studies regarding the efficacy and safety of pirfenidone.

The primary endpoint of change in percent predicted Forced Vital Capacity (FVC) at Week 72 was met with statistical significance in CAPACITY 2 (p=0.001). The secondary endpoints of progression-free survival (PFS) and categorical change in FVC were also met with statistical significance. The primary endpoint was not met in CAPACITY 1 (p=0.501), but supportive evidence of a pirfenidone treatment effect was observed on a number of measures, including the primary endpoint. Pirfenidone was safe and generally well tolerated in both CAPACITY studies. InterMune is preparing a New Drug Application (NDA) expected to be submitted to the FDA in the summer of 2009, to be followed by a Marketing Authorization Application (MAA) submission to the EMEA around the end of 2009.

Dr. Noble commented on the results, "CAPACITY 2 demonstrated a statistic
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
2. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
3. BioVex to Report Phase I/II Clinical Trial Results for the Front Line Treatment of Head and Neck Cancer With OncoVEX GM-CSF at the 2009 American Society of Clinical Oncology Meeting
4. TYRX Presents Early Clinical Results from AIGISRX(TM) Antibacterial Envelope Retrospective Registry
5. Metabolic Solutions Development Company Announces Preliminary Results from Phase IIa Clinical Trial
6. AlphaVax Announces Promising Results in Melanoma Studies
7. Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
8. BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
9. Bionovo Announces First Quarter 2009 Highlights and Financial Results
10. Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status
11. ADVENTRX Announces Results From ANX-514 Bioequivalence Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... , Aug. 22, 2014  Diplomat, the ... as one of two winners in the 2014 ... Pharmacy Solutions, LLC. The results of the competition ... Specialty Pharmacy News. Diplomat was ... University Education & Training program. Through Diplomat University, ...
(Date:8/22/2014)... 2014 Research and Markets  has announced ... Opportunities, Tools & Technologies" report to their offering. ... research products or you wish to expand your product ... market is. The authors know you want to make ... scientists, to generate improved revenues and take market share ...
(Date:8/22/2014)... -- Research and Markets has announced the ... Industry Report 2014" report to their offering. ... Report 2014 is a professional and in-depth study on ... with a focus on the Chinese situation. The ... definitions, classifications, applications and industry chain structure. The intravenous ...
Breaking Medicine Technology:Diplomat honored as a Top Innovator by Specialty Pharmacy News 2Global Stem Cell Research Products: Opportunities, Tools & Technologies - 2014 Report 2Global Stem Cell Research Products: Opportunities, Tools & Technologies - 2014 Report 3Global and Chinese Intravenous Catheter Industry Report 2014 2
... Cell Therapeutics, Inc. (the "Company") (NASDAQ and MTA: CTIC) ... "Board") approved a reverse stock split following the Company,s ... non-compliance from the staff of The NASDAQ Stock Market ... not regained compliance with NASDAQ Listing Rule 5550(a)(2) because ...
... Talnadge, a power wheelchair provided through Medicare is the ... to visit with friends and engage in the community, ... Those starkly different living environments are the only ... from muscular dystrophy and spina bifida.  These medical conditions ...
Cached Medicine Technology:Cell Therapeutics Announces Planned Reverse Stock Split; Receives NASDAQ Notice of Non-Compliance; Intends to Request Hearing 2Cell Therapeutics Announces Planned Reverse Stock Split; Receives NASDAQ Notice of Non-Compliance; Intends to Request Hearing 3Cell Therapeutics Announces Planned Reverse Stock Split; Receives NASDAQ Notice of Non-Compliance; Intends to Request Hearing 4Power Wheelchairs Keep Medicare Beneficiaries Out of Nursing Homes, While Reducing Government Costs and Providing More Freedom and Independence 2Power Wheelchairs Keep Medicare Beneficiaries Out of Nursing Homes, While Reducing Government Costs and Providing More Freedom and Independence 3Power Wheelchairs Keep Medicare Beneficiaries Out of Nursing Homes, While Reducing Government Costs and Providing More Freedom and Independence 4
(Date:8/23/2014)... Board of Directors voted on Monday, August 18th to approve ... for commercial and industrial properties. This was accomplished with ... in Carmel, California. , This is a historical moment, ... the State of California has approved this technology for use ... can now be used as a sole source of water ...
(Date:8/23/2014)... 23, 2014 Dealing with a drug or ... when the addict is a child. Adolescent addiction has been ... long time, but a new helpline is now providing a ... parents to find a real addiction recovery center. , The ... positive impact in the community. By calling (404) 975-2762, parents ...
(Date:8/23/2014)... vacation is almost over and before we know it schools ... school supplies and a new wardrobe might take precedence over ... also spend some time brushing up on bed bug prevention ... heavily populated places,” said Randy Rupert, Bed Bug Team Lead ... for bed bugs to take up residence.” , An already ...
(Date:8/22/2014)... On Friday, Aug. 22, Liberty University ... Sciences , hosting a ceremony in its courtyard attended ... and public welfare. , The 162-member inaugural class of ... (LUCOM) joined Liberty staff, faculty, and community leaders in ... new medical school. Classes began on Monday, Aug. 4. ...
(Date:8/22/2014)... Top 10 Best SEO Hosting (Top10BestSEOHosting.com) has ... highly recommended FatCow ( http://www.top10bestseohosting.com/go/FatCow.com/ ) and BlueHost ... 10 Best SEO Hosting states, “It is hard ... Actually, these companies have outperformed their competitors on ... People can get the best web hosting at ...
Breaking Medicine News(10 mins):Health News:Historical Moment in the Monterey Peninsula, Brings Drought Relief Solution to California, with the Help of EcoloBlue and AWG Technology 2Health News:Atlanta’s New Troubled Teen Helpline Is Making a Difference in the Community 2Health News:Expert Advice for a Bed Bug-Free School Year 2Health News:Liberty University Dedicates Its New Center for Medical and Health Sciences 2Health News:Liberty University Dedicates Its New Center for Medical and Health Sciences 3Health News:Liberty University Dedicates Its New Center for Medical and Health Sciences 4Health News:FatCow Reviews Released by Top10BestSEOHosting.com 2
... undertaken by a group of Spanish scientists, amongst which ... of Navarra and the Centre for Applied Medical Research// ... new line of treatment for patients with acute lymphoblastic ... been published in the official journal, Blood, of the ...
... is an independent risk factor for HIV infection, according ... of Sexually Transmitted Infections. The researchers conducted// a meta-analysis ... studies looking at the link between smoking and progression ... ,There is a growing recognition that smoking can ...
... are most likely to gain weight, a new study says//. ... aged nine and 10 and followed them for at least a ... cholesterol every year through age 18, then had the teens report ... the girls were white and half were black. ,The ...
... According to a recent study led by John-Dylan Haynes, ... cortex as subjects// concentrated on their choice of two ... activity patterns that correspond to the subjects' different plans. ... group led by John-Dylan Haynes of the Max Planck ...
... now for Trevis Smith, once- upon- a -time hero of Regina//. ... aggravated sexual assault last Thursday. , The 31-year-old football ... trial, which has been going on for some time. ... term of minimum two years and maximum, life. ,Two ...
... checkup in pregnant women to get underway soon//. ... mandatory in pregnant women, even if no symptoms of the ... slightly under active or a hyperactive thyroid gland during pregnancy ... lower IQ's. ,2-5 percent of women in general ...
Cached Medicine News:Health News:A New Treatment Discovered For Acute Lymphoblastic Leukemia 2Health News:Smoking Increases Risk of HIV Acquisition 2Health News:Adolescent Girls More Likely to Gain Weight: Study 2Health News:Reading Hidden Intentions in Brain 2Health News:Pregnant? Check Your Thyroid Secretion! 2
... Provides a more occlusive wrap than ... where wound transudate must be contained. Predictable ... be inert, nonantigenic, and nonpyrogenic. ,VICRYL (polyglactin ... synthetic absorbable copolymer of glycolide and lactide, ...
Used for implantation to reinforce soft tissue. Supplied sterile in peel-open packages. Intended for one-time use....
... mesh onlays are pre-cut and pre-shaped to ... are more frequently done. These pre-shaped onlays ... ProLite Ultra and are designed for use ... in both small and large sizes, they ...
... such as laparoscopic inguinal hernia repair ... a surgical biomaterial that enables rapid ... provides the answer to the most ... Made from strong, soft, inert and ...
Medicine Products: